awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36346020-2A19D3DE-2141-4BBD-8EAF-56CA725BC1F2
Q36346020-2A19D3DE-2141-4BBD-8EAF-56CA725BC1F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36346020-2A19D3DE-2141-4BBD-8EAF-56CA725BC1F2
BEAM: a randomized phase II study evaluating the activity of bevacizumab in combination with carboplatin plus paclitaxel in patients with previously untreated advanced melanoma.
P2860
Q36346020-2A19D3DE-2141-4BBD-8EAF-56CA725BC1F2
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36346020-2A19D3DE-2141-4BBD-8EAF-56CA725BC1F2
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
94fc58fb26ca5b627735b1a1391d7aa8f811d03e
P2860
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the Oblimersen Melanoma Study Group.